BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 133611)

  • 21. Metabolic clearance rate (MCR) of dehydroepiandrosterone sulfate (DS), its metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone, and the effect of increased plasma DS concentration on DS MCR in normal women.
    Haning RV; Chabot M; Flood CA; Hackett R; Longcope C
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1047-52. PubMed ID: 2529265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human fetal liver estrogen 16 alpha-hydroxylase: precursor specificity, kinetic parameters, and in vitro regulation.
    Milewich L; MacDonald PC; Guerami A; Midgett WT; Lassiter WL; Carr BR
    J Clin Endocrinol Metab; 1986 Jul; 63(1):180-91. PubMed ID: 3711258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5.
    Lee AJ; Kosh JW; Conney AH; Zhu BT
    J Pharmacol Exp Ther; 2001 Aug; 298(2):420-32. PubMed ID: 11454902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clearance rate of maternal plasma prehormones of placental estrogen formation.
    Gant NF; Worley RJ; MacDonald PC
    Perspect Nephrol Hypertens; 1976; 5():309-14. PubMed ID: 137386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of maternal intrahepatic cholestasis on fetal steroid metabolism.
    Laatikainen TJ; Peltonen JI; Nylander PL
    J Clin Invest; 1974 Jun; 53(6):1709-15. PubMed ID: 4275337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 16-alpha-hydroxylation of dehydroepiandrosterone by human fetal tissues.
    Nakayama T; Arai K; Sato K; Yanaihara T; Nagatomi K
    Endocrinol Jpn; 1967 Sep; 14(3):269-75. PubMed ID: 4229856
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma precursors of estrogen. III. Conversion of plasma dehydroisoandrosterone to estrogen in young nonpregnant women.
    MacDonald PC; Edman CD; Kerber IJ; Siiteri PK
    Gynecol Invest; 1976; 7(3):165-75. PubMed ID: 134938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of steroids by the pregnant mare. V. Metabolism of 14C-isopentenylpyrophosphate and 3H-dehydroisoandrosterone injected into the fetus.
    Bhavnani BR; Martin LJ; Baker RD
    Endocrinology; 1975 Apr; 96(4):1009-17. PubMed ID: 164338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic clearance rate of dehydroepiandrosterone sulfate, its metabolism to testosterone, and its intrafollicular metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone in vivo.
    Haning RV; Flood CA; Hackett RJ; Loughlin JS; McClure N; Longcope C
    J Clin Endocrinol Metab; 1991 May; 72(5):1088-95. PubMed ID: 1827126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A physiological increase in maternal cortisol alters uteroplacental metabolism in the pregnant ewe.
    Vaughan OR; Davies KL; Ward JW; de Blasio MJ; Fowden AL
    J Physiol; 2016 Nov; 594(21):6407-6418. PubMed ID: 27292274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.
    Baldwin SJ; Clarke SE; Chenery RJ
    Br J Clin Pharmacol; 1999 Sep; 48(3):424-32. PubMed ID: 10510156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placental steroid metabolism in a case of placental sulfatase deficiency.
    Gips H; Bailer P; Korte K
    J Endocrinol Invest; 1980; 3(1):51-8. PubMed ID: 6445378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fetal and maternal endocrine responses to reduced uteroplacental blood flow.
    Shepherd RW; Stanczyk FZ; Bethea CL; Novy MJ
    J Clin Endocrinol Metab; 1992 Jul; 75(1):301-7. PubMed ID: 1320054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse relation between low-density lipoprotein-cholesterol and dehydroisoandrosterone sulfate in human fetal plasma.
    Parker CR; Simpson ER; Bilheimer DW; Leveno K; Carr BR; MacDonald PC
    Science; 1980 May; 208(4443):512-4. PubMed ID: 6445079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NADPH-dependent metabolism of estrone by human liver microsomes.
    Lee AJ; Mills LH; Kosh JW; Conney AH; Zhu BT
    J Pharmacol Exp Ther; 2002 Mar; 300(3):838-49. PubMed ID: 11861789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal estradiol response to alterations in uteroplacental blood flow.
    Fritz MA; Stanczyk FZ; Novy MJ
    Am J Obstet Gynecol; 1986 Dec; 155(6):1317-25. PubMed ID: 2947471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental sulfatase deficiency: a case study.
    Osathanondh R; Canick J; Ryan KJ; Tulchinsky D
    J Clin Endocrinol Metab; 1976 Jul; 43(1):208-14. PubMed ID: 133115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic biotransformation of estradiol in human mammary explant cultures.
    Telang NT; Axelrod DM; Bradlow HL; Osborne MP
    Ann N Y Acad Sci; 1990; 586():70-8. PubMed ID: 2357012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiometric analysis of biological oxidations in man: sex differences in estradiol metabolism.
    Fishman J; Bradlow HL; Schneider J; Anderson KE; Kappas A
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4957-60. PubMed ID: 6933539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.